HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

HIVAC-1e

elicits a weak antibody & T-cell response in some people; no longer undergoing trials as an Aids Vaccine; studies are underway to examine HIVAC-1e in vaccinia-naive persons; recombinant vaccine using a vaccinia vector & gp160; coordinate with HIV envelope protein gp160(NM)
Networked: 3 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1. Vaccinia
2. Smallpox (Variola)

Related Drugs and Biologics

1. Antigens
2. Antibodies